<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08032595871880</udiDi>
    <basicUdiDi>803259587TF01EB</basicUdiDi>
    <tradeName>Cicatridina óvulos vaginales</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>2048</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:48.498Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595871927</udiDi>
    <basicUdiDi>803259587TF01EB</basicUdiDi>
    <tradeName>Cicatridina κολπικά υπόθετα</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1071</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:48.413Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595871934</udiDi>
    <basicUdiDi>803259587TF01EB</basicUdiDi>
    <tradeName>Cicatridina κολπικά υπόθετα</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>2050</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:48.391Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595871965</udiDi>
    <basicUdiDi>803259587TF01EB</basicUdiDi>
    <tradeName>Cikatridina Vaginalovula</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>2051</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:48.377Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595871972</udiDi>
    <basicUdiDi>803259587TF01EB</basicUdiDi>
    <tradeName>Cikatridina Vaginalovula</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1072</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:48.364Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595872054</udiDi>
    <basicUdiDi>803259587TF03EF</basicUdiDi>
    <tradeName>Cicatridine PLUS ovules vaginaux</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1078</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:48.314Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595872368</udiDi>
    <basicUdiDi>803259587TF03EF</basicUdiDi>
    <tradeName>CIKATRIDINE PLUS hüvelykúp</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1094</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:48.214Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595872375</udiDi>
    <basicUdiDi>803259587TF03EF</basicUdiDi>
    <tradeName>CIKATRIDINE PLUS hüvelykúp</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>2064</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:48.194Z</lastUpdated>
  </row>
  <row>
    <udiDi>08033776700869</udiDi>
    <basicUdiDi>8033776702287001J3</basicUdiDi>
    <tradeName>PLANFERTIL GEL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Crab Sinergy Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000008825</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PLF G 001</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:55:21.184Z</lastUpdated>
  </row>
  <row>
    <udiDi>08033776700944</udiDi>
    <basicUdiDi>8033776702287001J3</basicUdiDi>
    <tradeName>HYALSOLO GEL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Crab Sinergy Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000008825</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VHG 003 S</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:55:21.163Z</lastUpdated>
  </row>
  <row>
    <udiDi>08033776701316</udiDi>
    <basicUdiDi>8033776702287001J3</basicUdiDi>
    <tradeName>EPIBIOT GEL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Crab Sinergy Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000008825</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VHG005 IT</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:55:21.090Z</lastUpdated>
  </row>
  <row>
    <udiDi>08033776701361</udiDi>
    <basicUdiDi>8033776702287001J3</basicUdiDi>
    <tradeName>V-HYAL GEL</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Crab Sinergy Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000008825</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VHG002 MY</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:55:21.067Z</lastUpdated>
  </row>
  <row>
    <udiDi>08050046270235</udiDi>
    <basicUdiDi>805004627DEPOFARMA014003Q</basicUdiDi>
    <tradeName>Immunovag (Free sample - not for sale: 35 ml tube filled to 10 ml + 1 single-use vaginal applicator)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>DEPOFARMA S.P.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000027122</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1DEP01455</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:50:01.861Z</lastUpdated>
  </row>
  <row>
    <udiDi>08054529350179</udiDi>
    <basicUdiDi>805452935NVGN7</basicUdiDi>
    <tradeName>NOVOX GYNO 15ml</tradeName>
    <deviceName></deviceName>
    <manufacturerName>MOSS S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000010071</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NGT015S-EN</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:18:33.394Z</lastUpdated>
  </row>
  <row>
    <udiDi>08054529351329</udiDi>
    <basicUdiDi>805452935NVGN7</basicUdiDi>
    <tradeName>NOVOX GYNO - 15 ml</tradeName>
    <deviceName></deviceName>
    <manufacturerName>MOSS S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000010071</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NGT015S-ES</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:18:32.803Z</lastUpdated>
  </row>
  <row>
    <udiDi>08054529351343</udiDi>
    <basicUdiDi>805452935NVGN7</basicUdiDi>
    <tradeName>NOVOX GYNO - 15 ml</tradeName>
    <deviceName></deviceName>
    <manufacturerName>MOSS S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000010071</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NGT015S-SL</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:18:32.784Z</lastUpdated>
  </row>
  <row>
    <udiDi>08054529351350</udiDi>
    <basicUdiDi>805452935NVGN7</basicUdiDi>
    <tradeName>NOVOX GYNO - 15 ml</tradeName>
    <deviceName></deviceName>
    <manufacturerName>MOSS S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000010071</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NGT015S-EL</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:18:32.761Z</lastUpdated>
  </row>
  <row>
    <udiDi>08054529351435</udiDi>
    <basicUdiDi>805452935NVGN7</basicUdiDi>
    <tradeName>NOVOX GYNO 15ml</tradeName>
    <deviceName></deviceName>
    <manufacturerName>MOSS S.p.A.</manufacturerName>
    <manufacturerSrn>IT-MF-000010071</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NGT015S-DE</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:18:32.720Z</lastUpdated>
  </row>
  <row>
    <udiDi>08055748844500</udiDi>
    <basicUdiDi>805574884FTMDR110AC</basicUdiDi>
    <tradeName>Alegyne ovuli</tradeName>
    <deviceName></deviceName>
    <manufacturerName>GRUPPO FARMAIMPRESA SRL</manufacturerName>
    <manufacturerSrn>IT-MF-000012625</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Artık piyasada değil</deviceStatus>
    <reference>FT.MDR.110.ST</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:02:10.674Z</lastUpdated>
  </row>
</eudamedExport>